Acceleron Commences $100M Offering of Common Stock

by Charles Gross, Benzinga Editor
January 21, 2014 6:33 AM | 13 seconds read |
Acceleron Pharma XLRN today announced that it has commenced an underwritten public offering of $100 million of its common stock. All of the shares in the offering are to be sold by Acceleron. See full press release
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsGuidanceOfferingsManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!